dapsone has been researched along with Hidradenitis Suppurativa in 15 studies
Hidradenitis Suppurativa: A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 8.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "To evaluate the efficacy of dapsone in the treatment of hidradenitis suppurativa refractory to therapy with oral antibiotics and isotretinoin." | 7.73 | Hidradenitis suppurativa treated with dapsone: A case series of five patients. ( Kaur, MR; Lewis, HM, 2006) |
| "Dapsone was prescribed at doses of 50-150 mg/day." | 5.62 | Dapsone in hidradenitis suppurativa: A case series of 56 patients. ( Gamissans, M; López-Llunell, C; Riera-Martí, N; Romaní, J, 2021) |
| "Reactive arthritis is associated with chronic infections, such as HS, although joint involvement is uncommon." | 5.62 | Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa. ( Smith, H; Timofte, I, 2021) |
| "Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate." | 5.37 | Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011) |
| "We report its successful use in acne inversa." | 5.31 | [Acne inversa: a dapsone-sensitive dermatosis]. ( Hofer, T; Itin, PH, 2001) |
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 4.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "We present a case of fever, brain abscesses, and Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha (TNF-α) therapy in a 21-year-old acne inversa patient currently taking long-term dapsone." | 3.78 | Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. ( Asboth, F; Gattringer, KB; Graninger, W; Khalifeh, N; Koreny, M; Lagler, H; Mallouhi, A; Spertini, V; Thalhammer, F; Volc-Platzer, B; Vossen, MG; Willeit, M, 2012) |
| "To evaluate the efficacy of dapsone in the treatment of hidradenitis suppurativa refractory to therapy with oral antibiotics and isotretinoin." | 3.73 | Hidradenitis suppurativa treated with dapsone: A case series of five patients. ( Kaur, MR; Lewis, HM, 2006) |
| "Hidradenitis suppurativa is a common debilitating skin disease that has been neglected by science." | 2.53 | Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence. ( Gulliver, WP; van der Zee, HH, 2016) |
| "Although hidradenitis suppurativa is a common and serious skin condition, its treatment is not well established." | 2.52 | Update on Hidradenitis Suppurative (Part II): Treatment. ( García, FJ; Jiménez-Gallo, D; Martorell, A; Pascual, JC; Pereyra-Rodríguez, J; Salgado, L; Villarrasa, E, 2015) |
| "Dapsone was prescribed at doses of 50-150 mg/day." | 1.62 | Dapsone in hidradenitis suppurativa: A case series of 56 patients. ( Gamissans, M; López-Llunell, C; Riera-Martí, N; Romaní, J, 2021) |
| "Reactive arthritis is associated with chronic infections, such as HS, although joint involvement is uncommon." | 1.62 | Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa. ( Smith, H; Timofte, I, 2021) |
| "Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate." | 1.37 | Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011) |
| "We report its successful use in acne inversa." | 1.31 | [Acne inversa: a dapsone-sensitive dermatosis]. ( Hofer, T; Itin, PH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Llunell, C | 1 |
| Riera-Martí, N | 1 |
| Gamissans, M | 1 |
| Romaní, J | 1 |
| Ring, HC | 1 |
| Yao, Y | 1 |
| Maul, JT | 1 |
| Ingram, JR | 1 |
| Frew, JW | 1 |
| Thorsen, J | 1 |
| Nielsen, ML | 1 |
| Wu, JJ | 1 |
| Thyssen, JP | 1 |
| Thomsen, SF | 1 |
| Egeberg, A | 1 |
| Steyn, M | 1 |
| Ayis, S | 1 |
| O'Connor, J | 1 |
| Lakhan, MK | 1 |
| Ferguson, F | 1 |
| Shah, A | 1 |
| Rashidghamat, E | 1 |
| Baroudi, B | 1 |
| Bashyam, AM | 1 |
| Feldman, SR | 1 |
| Pichardo, RO | 1 |
| Murray, G | 1 |
| Hollywood, A | 1 |
| Kirby, B | 1 |
| Hughes, R | 1 |
| Timofte, I | 1 |
| Smith, H | 1 |
| Staub, J | 1 |
| Pfannschmidt, N | 1 |
| Strohal, R | 1 |
| Braun-Falco, M | 1 |
| Lohse, P | 1 |
| Goerdt, S | 1 |
| Leverkus, M | 1 |
| Martorell, A | 1 |
| García, FJ | 1 |
| Jiménez-Gallo, D | 1 |
| Pascual, JC | 1 |
| Pereyra-Rodríguez, J | 1 |
| Salgado, L | 1 |
| Villarrasa, E | 1 |
| van der Zee, HH | 1 |
| Gulliver, WP | 1 |
| Reddick, CL | 1 |
| Singh, MN | 1 |
| Chalmers, RJ | 1 |
| Yazdanyar, S | 1 |
| Boer, J | 1 |
| Ingvarsson, G | 1 |
| Szepietowski, JC | 1 |
| Jemec, GB | 1 |
| Vossen, MG | 1 |
| Gattringer, KB | 1 |
| Khalifeh, N | 1 |
| Koreny, M | 1 |
| Spertini, V | 1 |
| Mallouhi, A | 1 |
| Willeit, M | 1 |
| Volc-Platzer, B | 1 |
| Asboth, F | 1 |
| Graninger, W | 1 |
| Thalhammer, F | 1 |
| Lagler, H | 1 |
| Kozub, P | 1 |
| Simaljakova, M | 1 |
| Kaur, MR | 1 |
| Lewis, HM | 1 |
| Hofer, T | 1 |
| Itin, PH | 1 |
3 reviews available for dapsone and Hidradenitis Suppurativa
| Article | Year |
|---|---|
Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Topics: Acne Vulgaris; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Comb | 2015 |
Update on Hidradenitis Suppurative (Part II): Treatment.
Topics: 5-alpha Reductase Inhibitors; Adalimumab; Adrenal Cortex Hormones; Algorithms; Anti-Bacterial Agents | 2015 |
Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agent | 2016 |
12 other studies available for dapsone and Hidradenitis Suppurativa
| Article | Year |
|---|---|
Dapsone in hidradenitis suppurativa: A case series of 56 patients.
Topics: Adult; Dapsone; Female; Hidradenitis Suppurativa; Humans; Male; Retinoids; Retrospective Studies; Tr | 2021 |
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Topics: Acitretin; Anti-Bacterial Agents; Biological Factors; Biological Products; Clindamycin; Dapsone; Dic | 2022 |
Dapsone therapy for hidradenitis suppurativa: a retrospective review of characteristics and treatment outcomes in a cohort of 122 patients in a tertiary dermatology setting.
Topics: Dapsone; Dermatology; Hidradenitis Suppurativa; Humans; Retrospective Studies; Treatment Outcome | 2023 |
Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.
Topics: Adalimumab; Dapsone; Drug-Related Side Effects and Adverse Reactions; Hidradenitis Suppurativa; Huma | 2023 |
Dapsone therapy for hidradenitis suppurativa.
Topics: Dapsone; Hidradenitis Suppurativa; Humans | 2020 |
Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; Arthritis; Dapsone; Hidradenitis Suppurativa; Humans; Treatment Outcome | 2021 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Com | 2010 |
Dapsone therapy for hidradenitis suppurativa: a series of 24 patients.
Topics: Adult; Dapsone; Dermatologic Agents; Female; Glucosephosphate Dehydrogenase; Hidradenitis Suppurativ | 2011 |
Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.
Topics: Anti-Infective Agents; Antibodies; Bacteremia; Brain Abscess; Dapsone; Gemella; Gram-Positive Bacter | 2012 |
Hidradenitis suppurativa treated with combination of infliximab and dapsone.
Topics: Antibodies, Monoclonal; Dapsone; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans | 2012 |
Hidradenitis suppurativa treated with dapsone: A case series of five patients.
Topics: Adult; Aged; Anti-Infective Agents; Dapsone; Female; Hidradenitis Suppurativa; Humans; Male; Middle | 2006 |
[Acne inversa: a dapsone-sensitive dermatosis].
Topics: Acne Vulgaris; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic | 2001 |